Postoperative Morbidity Risks Following Ileocolic Resection for Crohn’s Disease Treated With Anti-TNF Alpha Therapy: A Retrospective Study of 360 Patients-Reference-Cited by-同舟云学术

Postoperative Morbidity Risks Following Ileocolic Resection for Crohn’s Disease Treated With Anti-TNF Alpha Therapy: A Retrospective Study of 360 Patients

Published:2018-01-18 Issue:2 Volume:24 Page:422-432
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Jouvin Ingrid¹,Lefevre Jérémie H¹,Creavin Ben²,Pitel Sophie¹,Chafai Najim¹,Tiret Emmanuel¹,Beaugerie Laurent³,Parc Yann¹,

Affiliation:

1. Department of General and Digestive Surgery, Hôpital Saint Antoine (AP-HP), Paris Sorbonne Université, Paris, France

2. Department of Surgery, St Vincent’s University Hospital, Elm Park, Dublin 4, Ireland

3. Department of Gastroenterology, Hôpital Saint Antoine (AP-HP), Paris Sorbonne Université, Paris, France

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/article-pdf/24/2/422/24616149/izx036.pdf

Reference42 articles.

1. Infliximab dependency is related to decreased surgical rates in adult Crohn’s disease patients;Pedersen;Eur J Gastroenterol Hepatol,2010

2. Trends in surgery for Crohn’s disease in the era of infliximab;Jones;Ann Surg,2010

3. Optimizing the safety of biologic therapy for IBD;de Silva;Nat Rev Gastroenterol Hepatol,2010

4. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: a multivariate analysis in 161 consecutive patients;Alves;Dis Colon Rectum,2007

5. Risk factors for intra-abdominal sepsis after surgery in Crohn’s disease;Yamamoto;Dis Colon Rectum,2000

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Full Guidelines—From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis;Journal of the American Academy of Dermatology;2024-08

2. Risk factors for major complications after surgical treatment of primary ileocecal Crohn's disease. A multicenter Latin American experience;Cirugía Española;2023-12

3. Risk factors for major complications after surgical treatment of primary ileocecal Crohn’s disease. A multicentric Latin American experience;Cirugía Española (English Edition);2023-12

4. Short‐term outcomes following total colectomy for inflammatory bowel disease in Denmark after implementation of laparoscopy: a nationwide population‐based study;Colorectal Disease;2023-08-03

5. Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease;Drugs;2023-07-28